BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16867030)

  • 1. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.
    Ishiwata A; Sakayori O; Minoshima S; Mizumura S; Kitamura S; Katayama Y
    Acta Neurol Scand; 2006 Aug; 114(2):91-6. PubMed ID: 16867030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.
    Huang C; Eidelberg D; Habeck C; Moeller J; Svensson L; Tarabula T; Julin P
    Neurobiol Aging; 2007 Jul; 28(7):1062-9. PubMed ID: 16824650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W; Schönauer U; Zauner H; Spindler I; Mair A; Iglseder B; Bernroider G; Ladurner G
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Okamura N; Shinkawa M; Arai H; Matsui T; Nakajo K; Maruyama M; Hu XS; Sasaki H
    Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Calvini P; Morbelli S; De Carli F; Guerra UP; Van de Pol LA; Visser PJ
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment.
    Huang C; Wahlund LO; Svensson L; Winblad B; Julin P
    BMC Neurol; 2002 Sep; 2():9. PubMed ID: 12227833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study.
    Hanyu H; Sato T; Hirao K; Kanetaka H; Iwamoto T; Koizumi K
    J Neurol Sci; 2010 Mar; 290(1-2):96-101. PubMed ID: 19931870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Devanand DP; Van Heertum RL; Kegeles LS; Liu X; Jin ZH; Pradhaban G; Rusinek H; Pratap M; Pelton GH; Prohovnik I; Stern Y; Mann JJ; Parsey R
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):959-72. PubMed ID: 20808143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.
    Nobili F; De Carli F; Frisoni GB; Portet F; Verhey F; Rodriguez G; Caroli A; Touchon J; Morbelli S; Guerra UP; Dessi B; Brugnolo A; Visser PJ
    J Alzheimers Dis; 2009; 17(4):761-72. PubMed ID: 19542623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment.
    Huang C; Wahlund LO; Almkvist O; Elehu D; Svensson L; Jonsson T; Winblad B; Julin P
    Neuroimage; 2003 Jul; 19(3):1137-44. PubMed ID: 12880839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT.
    Levy-Cooperman N; Lobaugh NJ; Caldwell C; Gao F; Black SE
    Dement Geriatr Cogn Disord; 2007; 24(5):380-8. PubMed ID: 17934273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of progression of Alzheimer's disease in younger versus older patients: a longitudinal single photon emission computed tomography study.
    Sakai M; Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Abe S; Kanaya K; Sakurai H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jul; 13(3):555-62. PubMed ID: 22963387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Cuberas-Borrós G; Vinyes-Junqué G; Espinosa A; Valero S; Hernández I; Roca I; Ruíz A; Rosende-Roca M; Mauleón A; Becker JT; Castell-Conesa J; Tárraga L; Boada M
    J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
    Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
    Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of functional neuroimaging in the progression of mild cognitive impairment.
    Cabranes JA; De Juan R; Encinas M; Marcos A; Gil P; Fernández C; De Ugarte C; Barabash A
    Neurol Res; 2004 Jul; 26(5):496-501. PubMed ID: 15265266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.